• Reciprocal Tariffs Onerous, Pharma-Specific Tariffs on Hold

  Published On: 04/03/2025

• FDA: Outlook for Drug Reviews, Policy & PDUFA

  Published On: 04/02/2025

• Lab Developed Test Rules Gone

  Published On: 03/31/2025

• FDA Staff Cuts, PDUFA & Peter Marks’ Departure

  Published On: 03/31/2025

• BIOSECURE Unlikely in 2025

  Published On: 03/28/2025

• Trump Healthcare Executive Actions (To Date)

  Published On: 03/27/2025

• PBM Reform & Reconciliation Update

  Published On: 03/26/2025

• Biopharma: International Pricing & Tariffs Are Intertwined

  Published On: 03/26/2025

• CMS Administrator Nominee Oz Clears Committee

  Published On: 03/25/2025

• Unlocking Investment for Women’s Health

  Published On: 03/25/2025

• Health Policy Peek: Week Of March 24-28

  Published On: 03/23/2025

• CMS Administrator Nominee Oz Moves One Step Closer

  Published On: 03/14/2025

• NIH’s Bhattacharya & FDA’s Makary Confirmations Move Forward

  Published On: 03/13/2025

• Health Policy Peek: Week Of March 10-14

  Published On: 03/07/2025

• FDA Commissioner Likely to be Confirmed in March

  Published On: 03/06/2025

• Capitol Street Drug Negotiation (IRA) Tracker

  Published On: 03/05/2025

• Health Policy Peek: Week Of March 3-7

  Published On: 02/28/2025

• CMS’s Center for Innovation Outlook in a Trump World

  Published On: 02/27/2025

• March Confirmation Hearings for NIH, FDA & CMS Nominees

  Published On: 02/25/2025

• Trump Healthcare Executive Actions (To Date)

  Published On: 02/19/2025

Previous456Next